Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies

Developmental and epileptic encephalopathies (DEEs) are rare neurodevelopmental disorders characterised by early-onset and often intractable seizures and developmental delay/regression, and include Dravet syndrome and Lennox–Gastaut syndrome (LGS). Rufinamide, fenfluramine, stiripentol, cannabidiol...

Descripción completa

Detalles Bibliográficos
Autor principal: Sills, Graeme J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467199/
https://www.ncbi.nlm.nih.gov/pubmed/37655228
http://dx.doi.org/10.1177/17562864231191000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467199/
https://www.ncbi.nlm.nih.gov/pubmed/37655228
http://dx.doi.org/10.1177/17562864231191000

Ejemplares similares